12 February 2026 | Thursday | News
Picture Courtesy | Public Domain
Tradr ETFs, a provider of exchange-traded funds designed for sophisticated investors and professional traders, has launched two new leveraged inverse ETFs offering targeted exposure to single stocks. The Cboe-listed funds seek to deliver -200% of the daily performance of their respective underlying equities.
The newly launched ETFs, expected to begin trading today, include:
Tradr 2X Short BE Daily ETF (Cboe: BEZ) – targeting Bloom Energy Corp. (NYSE: BE)
Tradr 2X Short SMR Daily ETF (Cboe: SMZ) – targeting NuScale Power Corp. (NYSE: SMR)
Both funds represent first-to-market strategies, providing traders with amplified inverse exposure to two highly volatile clean energy and nuclear power equities.
“With $150 million of assets between them, our long strategies on Bloom Energy and NuScale have been enthusiastically embraced by traders,” said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. “However, these names are quite volatile and are prone to large swings on both up and down moves. With these inverse strategies, traders now have another tool to express a high-conviction view if momentum gets stretched or valuation gets too rich.”
Tradr’s growing lineup now includes 64 leveraged ETFs, representing more than $2 billion in assets under management. The firm’s products are accessible through most major brokerage platforms and are designed to provide sophisticated investors with leveraged exposure without the need for margin accounts or options trading.
The launch underscores Tradr’s continued focus on delivering innovative trading tools that allow investors to express directional market views with precision and efficiency.
Investors are encouraged to review detailed fund information and understand the significant risks associated with leveraged ETFs before investing. Additional information is available at www.tradretfs.com
Fintech Business Asia, a business of FinTech Business Review
© 2026 FinTech Business Review. All Rights Reserved.